Salute e Benessere
PCR Technologies Market Share Worth $24.52 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
: https://www.theinsightpartners.com/sample/TIPRE00003069/
https://www.theinsightpartners.com/sample/TIPRE00003069/
Advancements in molecular biology, increased demand for rapid diagnostic solutions, and expanding applications of PCR technology in the healthcare research and environment sectors are accelerating growth and innovation in the PCR technology market. Digital PCR, multiplexing, and next-generation sequencing integration contribute to accuracy in genetic analysis. The acceptance of personalized medicine and point-of-care testing would fuel further expansion in the PCR technologies market. Moreover, automated systems and user-friendly software for primer design would automate the process, and make research and clinical use accessible to all. Stakeholders in the PCR technology marketplace plan to focus on all emerging trends and innovations to fully tap its potential to address modern-day scientific and medical problems. The report from The Insight Partners, therefore, provides several stakeholders—including component providers, system technology integrators, and system manufacturers—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
https://www.theinsightpartners.com/sample/TIPRE00003069/
PCR (Polymerase Chain Reaction) is a crucial tool in clinical settings due to its ability to amplify specific DNA and RNA sequences, enabling rapid and accurate detection of genetic variants, infectious diseases, and biomarkers. This molecular biology technique has revolutionized research, diagnostics, and various other applications. The increasing prevalence of chronic diseases and advancements in genomic research have further driven the demand for PCR-based diagnostics. As a result, PCR plays a key role in areas such as early detection of diseases, genetic testing, and the identification of pathogens.
Technological advancements in PCR, including automation, integration with software, and improvements in instruments and chemicals, have led to increased performance, sensitivity, and efficiency. These developments have made PCR workflows faster, more accurate, and cost-effective, contributing to the expanding market. Real-time PCR (qPCR) and portable systems, for example, have enhanced diagnostic capabilities, making PCR applicable in remote and point-of-care settings.
Overall, PCR's continuous evolution and its diverse applications across healthcare, agriculture, and research have cemented its importance in modern molecular diagnostics.
Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research. In February 2019 , Genome Canada partnered with the federal government of Canada and various provincial governments, companies, and research groups. Genome Canada received ~US$ 42.6 million through these partnerships in funding for bioinformatics and human health genomics projects. Visby Medical, an infectious disease diagnostics company based in the US, obtained funding from the National Institutes of Health (NIH) in October 2020 for Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative.
In 2021, Camena Bioscience, a synthetic biology startup that supplies genes to the biotechnology and pharmaceutical sectors, completed a
US$ 10 million Series A funding round headed by Mercia. With the additional funds, the company expanded its operations and continued the development of its ground-breaking DNA synthesis platform—gSynth. The technology platform and other related resources help the company accelerate the development of gene synthesis. Several companies have also increased their research and development funds to enhance gene synthesis. In 2020, EVONETIX LTD, a synthetic biology startup that creates a desktop platform for high-fidelity, rapid, and scalable gene synthesis, announced the completion of its Series B financing round. The company, led by new investor Foresite Capital, raised
US$ 30 million (£23 million) in this round. Therefore, increasing financial support for research and development in disease-specific genomics propels the demand for PCR technologies.
Size and Forecasts 2021 – 2031
- Overview, Size, Share by 2031
Size and Forecasts 2021 – 2031
Size and Forecasts 2021 – 2031
Size, Demand, and Forecast | 2031
Analysis, Growth, Size, Share - 2030
Size, Scope, Growth & Outlook 2030
Analysis, Size, Share, Growth, Trends, and Forecast by 2030
Size Report | Global Share & Growth Outlook 2030
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Ankit Mathur
:
ankit.mathur@theinsightpartners.com
: +1-646-491-9876
https://www.theinsightpartners.com/pr/pcr-technologies-market
View original content: https://www.prnewswire.co.uk/news-releases/pcr-technologies-market-share-worth-24-52-billion-globally-by-2030---exclusive-report-by-the-insight-partners-302279381.html